Article PDF
Literature
Rietschel, E., Zähringer, U., Wollenweber, H. W., Miragliotta, G., Musehold, J., Lüderitz, T., Schade, U. Bacterial Endotoxins. Chemical Structure and Biologic Activity. Amer. J. Emergency Med. 2 (1984) 60–69.
Young, L. S., Stevens, P., Kajser, B. Gram-negative pathogens in septicaemic infections. Scand. J. Infect. Dis. Suppl. 31 (1982) 78–94.
McCabe, W. R., Jackson, G. G.: Gram-negative bacteremia. I. Etiology and ecology. Arch. Intern. Med. 110 (82) 847–855.
Galanos, C., Freudenberg, M. A., Jay, F. A., Nerkar, D., Veleva, K., Brade, H., Strittmatter, W. Immunogenic properties of lipid A. Rev. Infect. Dis. 6 (1984) 546–552.
Lüderitz, O., Freudenberg, M. A., Galanos, C. Lipopolysaccharides of gram-negative bacteria. In:Razin, C. S., Rottem, S. (eds.. Microbial membrane lipids, 17. New York: Academic Press, 1982, pp. 79–151.
Yasuda, T., Kanegasaki, S., Tsumita, T. Biological activity of chemically synthesized lipid A analogues: Demonstration of adjuvant effect in hapten-sensitized liposomal system. Eur. J. Biochem. 124 (1982) 405–407.
Lüderitz, O., Galanos, C., Rietschel, E. T. Endotoxins of gramnegative bacteria. Pharmacol. Ther. 15 (1982) 383–402.
Jacob, H. S., Craddock, P. R., Hammerschmidt, D. E., Moldow, C. F. Complement-induced granulocyte aggregation. New Engl. J. Med. 302 (1980) 789–794.
Sprung, G. L., Schultz, D. R., Marcial, E., Caralis, P. V., Gelbard, M. A., Arnold, P. I., Long, W. M. Complement activation in septic shock patients. Crit. Care Med. 14 (1986) 525–528.
Grob, P. J., Holch, M., Brunner, W. Posttraumatisches/postoperatives Immundefektsyndrom Schweiz. Med. Wochenschr. 117 (1987) 471–480.
Freudenberg, M. A., Bog-Hansen, T. C., Back, U. Interaction of lipopolysaccharides with plasma high density lipoprotein. Infect. Immun. 28 (1980) 373–380.
Duswald, K. H. Zur Pathobiochemie der Leukozyten-Elastase und ausgewählter Plasmaproteine bei Sepsis nach abdominal-chirurgischen Eingriffen. G-I-T-Verlag Ernst Giebeler, Darmstadt, 1983.
Aketagawa, J., Miyata, T., Ohtsubo, S., Nakamura, T., Morita, T., Hayshida, H., Miyata, T., Sadaaki, I. Primary structure of limulus anticoagulant antilipopolysaccharide factor. J. Biol. Chem. 261 (1986) 7357–7365.
Nakamura, T., Morita, T., Iwanaga, S. Lipopolysaccharide-sensitive serine-protease zymogen (factor C) found in limulus hemocytes. Eur. J. Biochem. 154 (1986) 511–521.
Munford, R. S., Hall, C. L., Rick, P. D. Size heterogeneity ofSalmonella typhimurium lipopolysaccharides in outer membranes and culture supernatant membrane fragments. J. Bacteriol. 144 (1980) 630–640.
Marget, W., Weiß, M., Ruhland, B. Lipid A antibody determination using ELISA on patients at a children's hospital: a preliminary report. Infection 11 (1983) 84–86.
Stoll, C., Schedel, I., Peest, D. Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma. Infection 13 (1985) 115–119.
Dupuis, G., Glauser, M. P. Mortalité au cours de 131 épisodes de septicéma à germes gram négatifs l' hôpital universitaire de Lausanne en 1979. Schweiz. Med. Wochenschr. 112 (1982) 46–48.
Glinz, W., Grob, P. J., Nydegger, U. E., Ricklin, T. Stamm, F., Stoffel, D., Lasance, A. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. Intens. Care Med. 11 (1985) 288–294.
Baumgartner, J. D., Glauser, M. P., McCutchan, J. A., Ziegler, E. J., van Melle, G., Klaubner, M. R., Vogt, M., Muehlen, E., Lüthy, R., Chiolero, R., Geroulanos, S. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. LancetI (1985) 59–63.
Marget, W., Mar, P. J., Jaspers, L., Possinger, K., Haslberger, H. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection 13 (1985) 120–124.
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J., Douglas, H., Braude, A. I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant ofEscherichia coli. N. Engl. J. Med. 307 (1982) 1225–1230.
Stephan, W., Dichtelmüller, H., Schedel, I. Eigenschaften und Wirksamkeit eines humanen Immunglobulin M-Präparates für die intravenöse Anwendung. Arzneim.-Forsch./Drug Res. 35 (I) (1985), 933–936.
Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E., Braude, A. I. Treatment ofE. coli andKlebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal epimerase-deficient mutant. J. Immunol. 111 (1973) 433–438.
Tympner, K. D., Stephan, W., Linderkamp, O. Intravenöse IgM-Applikation. Monatsschr. Kinderheilk. 123 (1975) 400–401.
Shenep, J. L., Mogan, K. A. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. Infect. Dis. 150 (1984) 330–388.
Kreger, B. E., Craven, D. E., Carling, P. C., McCabe, W. R. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Amer. J. Med. 68 (1980) 332–343.
Kreger, B. E., Craven, D. E., McCabe, W. R. Gram-negative bacteremia. IV. Recevaluation of clinical features and treatment in 612 patients. Amer. J. Med. 68 (1980) 344–55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schedel, I. New aspects in the treatment of gram-negative bacteraemia and septic shock. Infection 16, 4–7 (1988). https://doi.org/10.1007/BF01646920
Issue Date:
DOI: https://doi.org/10.1007/BF01646920